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Abstract
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The pH sensitive contrast agent, GdDOTA-4AmP (Gd1) has been successfully used to map tissue
pH by MRI. Further studies now demonstrate that two distinct chemical forms of the complex can
be prepared depending upon the pH at which Gd3+ is mixed with ligand 1. The desired pH sensitive
form of this complex, referred to here as a Type II complex, is obtained as the exclusive product only
when the complexation reaction is performed above pH 8. At lower pH values, a second complex is
formed that, by analogy with an intermediate formed during preparation of GdDOTA, we tentatively
assign this to a Type I complex where the Gd3+ is coordinated only by the appended side-chain arms
of 1. The proportion of Type I complex formed is largely determined by the pH of the complexation
reaction. The magnitude of pH dependent change in relaxivity of Gd1 was found to be less than
earlier reported (S. Zhang, K. Wu, and A. D. Sherry, Angew. Chem., Int. Ed., 1999, 38, 3192), likely
due to contamination of the earlier sample by an unknown amount of Type I complex. Examination
of the NMRD and relaxivity temperature profiles, coupled with information from potentiometric
titrations, shows that the amphoteric character of the phosphonate side-chains enables rapid
prototropic exchange between the single bound water of the complex with those of the bulk water
thereby giving Gd1 a unique pH dependent relaxivity that is quite useful for pH mapping of tissues
by MRI.
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The measurement of pH in vivo is an important goal in the diagnosis and aetiology of kidney
disease and cancer.1–4 Although tissue pH can be measured using microelectrodes,2, 3
electrodes are invasive and can only provide a very low resolution distribution of tissue pH.
Various NMR spectroscopic approaches have also been used in vivo but they generally suffer
from low sensitivity and spatial resolution. Magnetic resonance imaging (MRI) on the other
hand provides exquisite anatomical resolution because the MRI signal is largely derived from
abundant tissue water so this might be the technique of choice for mapping tissue pH from
organs deep with the body. Although MRI contrast agents have been used for over two decades,
5,6 none of the clinically approved agents are sensitive to tissue pH. To be useful as a pH
reporter, a contrast agent must meet several criteria. The complex must be thermodynamically
stable and kinetically inert so that Gd3+ is not released in vivo,5 the complex itself must be
non-toxic, the relaxivity of the complex should respond to changes in pH over the extremes of
tissue pH (~pH 5–8)2,3 and, ideally, the relaxivity of the complex should not be sensitive to
endogenous metal ions, anions or proteins.7 A number of agents that exhibit changes in
relaxivity with pH have been reported8–12 and among them is Gd1 (GdDOTA-4AmP), an
agent that displays a pH sensitive relaxivity profile that is nearly ideal for in vivo applications.
13 Indeed, pH maps of mouse kidney and implanted tumors have been recorded by MRI using
this agent.14–16 In this paper, we report studies that examined the relaxation and complexation
properties of Gd1 (Chart 1) in more detail.
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Results and Discussion
Synthesis
The ligand 1 was synthesized by the route described in Scheme 1. Diethyl phosphite and
bromomethyl phthalimide were mixed and heated without solvent.17 The ethyl bromide that
evolved during the reaction was removed by distillation to afford 3 in 99% yield. The
phthalimide group was then removed with hydrazine in ethanol.17,18 After column
chromatography over silica gel, the amine 4 was reacted with bromoacetyl bromide to afford
the bromoacetamide 5. Alkylation of cyclen with the bromoacetamide 5 afforded the protected
ligand 6 in 61% yield. The ethyl esters were removed using 30% HBr in acetic acid to liberate
1 in 30% overall yield.
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As a general rule, lanthanide complexes of simple DOTA-tetraamide ligands like DOTAM
(Chart 1) are readily prepared in acetonitrile by mixing the unprotonated form of the ligand
with a lanthanide triflate salt or in water by mixing the ligand with either a lanthanide triflate
or lanthanide chloride salt.12,19,20 In aqueous media, the pH of the complexation reaction is
an important consideration; lanthanides form insoluble hydroxides above pH ~621 while
reactions run at lower pH values can be quite slow. As a consequence, complexation reactions
in water are usually carried out under mildly acidic conditions, typically between pH 5–6.12,
20 Since the ligand 1 is isolated as a hydrobromide salt using the method described in Scheme
1, the complexation reaction must be performed in water for solubility reasons. However, in
this case, upon mixing a lanthanide salt with the ligand under acidic conditions, i.e. normal
complexation conditions, the expected, symmetric, complex structure is not the predominant
reaction product. If the reaction pH is low enough then a single structure of lower symmetry
is formed exclusively. This is best illustrated by the 1H NMR spectrum of the ytterbium
complex prepared at pH 1 (Figure 1a).
When the reaction is performed at higher pH values, an increasing amount of the desired,
symmetric product is formed. Furthermore, in contrast to most complexation reactions
involving lanthanides with DOTA-type ligand systems, raising the pH above ~6 does not result
in the precipitation of the lanthanide.21 In fact, in this system, the pH can be raised above 10
Inorg Chem. Author manuscript; available in PMC 2008 September 12.
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without observable precipitation. This was an important observation because it is not until the
pH of the reaction mixture exceeds 8 that the desired highly symmetrical complex is obtained
as the exclusive product. This is seen in the 1H NMR spectrum of the ytterbium complex formed
at pH 9 (Figure 1b). Similar results were obtained for other lanthanide complexes.

NIH-PA Author Manuscript

The difference between the NMR spectrum of the desired product and that of the complex
formed under acidic conditions is marked. The desired product shows eight resonances of equal
intensity, consistent with the expected C4-symmetry of the complex. Furthermore, the
characteristic lanthanide induced shift (LIS) pattern of the DOTA-type framework22,23 is
evident. In contrast, sixteen hyperfine shifted, relatively sharp resonances of equal intensity
are evident in the 1H NMR spectrum of the structure formed at low pH, consistent with
formation of a different, yet well-defined, complex with C2-symmetry. Although further
studies will be required to determine the detail of this structure, it is postulated that this species
has a structure similar to that of the intermediate formed during the synthesis of LnDOTA−
complexes. In this intermediate, often referred to as a Type I complex, the lanthanide ion sits
well above the cyclen ring coordinated only to the four appended carboxyl groups and several
water molecules.24 The assignment of a Ln1 species formed at low pH to a Type I complex is
supported by the absorption spectra of the cerium complexes prepared at pH 1 and pH 9. The
4f1 → 4f05d1 transition of the cerium ion is found to be extremely sensitive to the coordination
environment of the cerium ion and has been reported to be a useful probe of the interconversion
of Type I and Type II complexes.24,25 These spectra (Figure 2) show that the Ce1 complex
formed at low pH has an absorption maximum similar to that of the Type I complex of CeDOTA
so one can conclude that the Ce3+ ion is probably coordinated only by oxygen donors above
the macrocyclic ring. The macrocyclic ring does not participate in coordination of the metal
ion in this structure presumably because of electrostatic repulsion between the trivalent
lanthanide ion and the protonated macrocyclic ring nitrogen atoms. Although usually very
short-lived in solution, a crystal structure of a Type I complex of LnDOTAM has been obtained
by Parker and co-workers in which the coordination shell of the lanthanide ion is completed
by 4 water molecules.26 In the case of Ln1, it is reasonable to assume that the phosphonate
groups of the pendant arms, which have a high affinity for hard metal ions like the lanthanide
ions, are also involved in binding the metal ion to form a Type I complex. This results in a
stable structure that, once formed, will persist in solution under acidic conditions for months.
It is possible to convert the Type I structure to the more desirable, and more thermodynamically
stable, Type II complex by raising the pH. These observations highlight the importance of
controlling the reaction pH when synthesizing the lanthanide complexes of 1. To achieve the
more highly desired pH sensitive, Type II complex, the reaction should be performed above
pH 8 and preferably around pH 9.
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pH responsive relaxometry studies
The pH dependent relaxivity curve of Gd1 is illustrated in Figure 3. These data were collected
by starting with a 1 mM solution of the Type II complex prepared at pH 9, as described
previously, adjusting the pH of the sample to ~2 by addition of hydrochloric acid, and, after
each T1 measurement, the sample pH was raised by addition of small quantities of solid lithium
hydroxide monohydrate. Lithium hydroxide was chosen for pH adjustment because the effect
of the lithium ion on the complex was so small that it could not be detected by potentiometry
(see below). The pH profile obtained this way retains many of the features of other pH profiles
reported for simple tetraamide complexes.12,20 In particular, at low pH the relaxivity is high
(8.5 mM−1s−1) but then falls off sharply as the pH is increased to pH 4.5 after which it begins
to increase again (Figure 3). This is where the pH profile of Gd1 deviates from those of simpler
tetraamide derivatives. Whereas the relaxivity of most other tetraamide derivatives minimizes
around pH 3 and remains low up to pH ~9, the relaxivity of Gd1 rises from 4.4 mM−1s−1 at

Inorg Chem. Author manuscript; available in PMC 2008 September 12.
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pH 4.5 and reaches a maximum of 5.3 mM−1s−1 at pH 6.3, then falls off again as the pH is
raised above 6.3 until it reaches a minimum of 3.4 mM−1s−1 above pH 9.
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Although the pH profile shown in Figure 3 differs in the magnitude of the change in relaxivity
from that originally reported for Gd1,13 it does retain the same broad characteristics. The
accuracy of this new profile was independently verified by recording nuclear magnetic
relaxation dispersion (NMRD) profiles of a different sample of carefully prepared Gd1 at three
temperatures over the pH range 5 – 8.5 (Figure 4). The NMRD profiles recorded at 25°C show
the same trend and relaxivity values with changing pH at 20 MHz as the pH profile reported
in Figure 3. Furthermore, a profile corresponding to that previously published13 could be
obtained by preparing a sample of Gd1 at a pH known to be too low to allow complete formation
of the Type II complex. When the pH profile of a sample initially prepared at pH 4 was
measured using a identical protocol as that described for Figure 3, the profile closely resembled
the one previously reported.13 Presumably the Type I complex has a greater contribution to
relaxation at the lower end of the pH scale. As the pH is increased, the complex is gradually
converted into the Type II complex and thus the profiles display similar relaxivities by pH 9.
It should be noted that the Type II complex was used to generate the in vivo maps of tissue pH
using this compound as evidenced by the similarity of the pH dependent relaxivity curves
published in those papers14–16 with those of Figure 3.
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Inspection of the NMRD profiles of Figure 4 provides further insights into this pH sensitive
complex. The profiles display a general shape that is similar to other low molecular weight
DOTA-type chelates of Gd3+. In the region of interest for imaging, i.e., above 10 MHz, the
measured relaxivity can be affected by the hydration number (q), the water exchange rate (1/
τM) and the rotational correlation time of the complex (τR).27–31 For typical low molecular
weight chelates, rapid molecular reorientation largely determines the observed relaxivity. As
molecular reorientation is slowed, the relaxivity near 20–30 MHz increases and this is typically
seen in an NMRD profile as a characteristic high field “hump”.32,33 The absence of this
“hump” in any of the NMRD profiles of Gd1 shows that the complex undergoes rapid molecular
reorientation at all pH values. Thus, we may conclude that the pH responsive behaviour of
Gd1 does not originate with changes in τR arising from pH dependent aggregation of the
complex.33 Since q has also been shown to be pH independent in this complex (q = 1),13 the
origin of the pH response at high fields must reflect changes in the water (or proton) exchange
rate (1/τM) or changes in the second hydration sphere with changing pH.34 The relaxivity of
this complex also displays a different temperature dependence at each pH value (discussed
further below), a further indication that τM is the factor most influenced by changes in pH in
this complex.
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It is important to note that the rate of water molecule exchange as determined by variable
temperature 17O NMR experiments on the Dy1 complex is unaffected by changes in pH.13
However, bulk water relaxation in this system does not require rapid molecular exchange when
proton exchange would have the same effect on measured relaxivity values. This is indeed the
case for Gd1. Given that the constitution of Gd1 is so important to the observed pH dependent
relaxivity behaviour, and perhaps also the stability and safety of the complex, there is a clear
need for a reliable assay of the products of the complexation reaction prior to use of this
complex as a pH sensor. Since the electronic properties of gadolinium preclude the use of NMR
for this purpose, an alternative technique was sought.
Potentiometric Studies
The protonation constants of the ligand 1 were determined by potentiometric titration, eight
protonation steps were found in the pH range 1.7 – 12.5 (Table 1). Although the same number
of protonation steps was observed in the presence of Me4N+ and K+, the protonation constants
in KCl were significantly depressed relative to Me4NCl, especially K1H. This indicates that
Inorg Chem. Author manuscript; available in PMC 2008 September 12.
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the K+ ion is not completely inert with respect to 1 and does in fact form a weak complex with
the ligand.
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When comparing these protonation constants with those of other DOTA-tetraamide
derivatives,25,35 it is clear that the highest constant can be assigned to the first protonation of
the cyclen ring. While the two highest protonation constants in systems such as these can
typically be traced to macrocyclic nitrogen atoms,36–38 this system is less clear because at
least four of the six highest protonation constants must correspond to four PO32− → PO3H−
protonation steps, one on each of the four pendant arms.39 Thus, while the first six protonation
steps can be assigned to two of the macrocylic amines and four phosphonates, the next two
protonation steps are more difficult to assign. Only rarely is a third protonation step for the
cyclen ring observed in this range25,35 and yet the log K values, 2.46 and 1.92, are in the range
expected for further protonation of the macrocyclic ring. However, these two protonation
constants are also in the range expected for a second phosphonate protonation step, PO3H− →
PO3H239 so further studies will be necessary to delineate the exact microscopic sites of these
final two protonation steps.
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Further titrations of 1 were performed in the presence of variable amounts of Na+, K+ or
Ca2+ in a constant ionic background of 1.0 M Me4NCl. The stabilities of complexes formed
between these ions and 1 are summarized in Table 2. Although K+ forms the weakest complex
of these three ions, its interaction with 1 is still significant. Among these three ions, Ca2+, not
surprisingly, forms the most stable complex with 1, the magnitude of which is similar to that
observed for other DOTA-tetraamide ligands.25,35 Unless a Type I complex is formed
between Ca2+ and 1 that is particularly strong, a log KCaL value of 11.16 suggests that this
reflects a Type II complex where the Ca2+ is bound by the macrocyclic ring as well as the
amide oxygen atoms. This is supported by the observation that the pH was slow to stabilize
after each addition of base, consistent with relatively slow formation kinetics of a Type II
Ca1 complex since formation of a Type I complex would be expected to be rapid.
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Although the coordination chemistry and size of the Ca2+ ion is similar to the lanthanide ions,
potentiometric titrations of 1 in the presence of Gd3+ showed quite different behaviour from
that of Ca2+. In this case, there was an initial rapid release of protons when Gd3+ was added
to the ligand 1 under acidic conditions, presumably the result of release of phosphonate bound
protons during formation of a Type I complex. We have already seen that the greater nuclear
charge of the Gd3+ ion results in a strong interaction with the phosphonates under these
conditions. Although the results of NMR and spectrophotometric experiments have shown that
conversion to a Type II complex does occur as more base is added, this process is slow.
Furthermore, as the Gd3+ ion drops into the ligand cage it ceases to bind to the phosphonate
groups and these groups are then able to act as buffers to absorb protons released during
movement of the Gd3+ ion into the macrocyclic ring. These two effects, in combination, explain
why subsequent evolution of protons in the titration of 1 with Gd3+ was not observed. Since
the release of protons from the macrocycle cannot be measured during this rearrangement, a
stability constant for Gd1 cannot be determined by potentiometry alone. However, it is possible
to approximate the stability constant for Gd1 by extrapolating from the value found for the
Ca2+ system. In general, the log KGdL values for Gd3+ complexes in other DOTA-tetraamide
systems are a factor of 1.3 – 1.4 greater than those measured for the corresponding Ca2+
complexes,25,35 so one can estimate with some confidence that the value of log KGdL for
Gd1 lies between 14.2 and 15.6 based upon the log KCaL value measured here for Ca1 (Table
2). Given that pH changes are detected during formation of Ca1, this also lends support to the
idea that Ca2+ does not form the same stable Type I complex with 1 as do the lanthanide ions.
The protonation constants of a sample of Gd1, prepared at pH 9 such that only the Type II
complex was present, were also determined by potentiometric titration. The values of these
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protonation constants (Table 3) are in the same range as those determined by titration of the
ligand alone. If the phosphonate groups of the ligand pendant arms are able to participate in
metal ion binding, resulting in an unusually stable Type I complex with lanthanide ions, then
the question of their involvement in metal binding once the complex with Gd3+ has been formed
should also be addressed. Accordingly, potentiometric titrations of the Type II complex of
Gd1 were performed also in the presence of Ca2+, Cu2+ and Zn2+. Each of these metal ions
was found to form a Gd1·M complex with log KGdLM values ranging from 1.87 to 5.39 (Table
4). Although Ca2+ forms the weakest ternary complex of the three metal ions studied, the
potential for interference by calcium is perhaps greatest because it is present in much higher
concentrations in vivo than either Cu2+ or Zn2+. Although the total concentration of Zn2+ and
Cu2+ in vivo are ≈16 µM and ≈18 µM, respectively, the concentrations of these ions available
for exchange are even lower, [Zn2+] ≈ 10 µM, [Cu2+] ≈ 1.0 µM.40 In contrast the concentration
of calcium in vivo can be as high as 2.5 mM.40 Binding of zinc or copper by Gd1 is unlikely
to have any significant effect on the pH dependent relaxivity curve but the effect of calcium
binding on a typical MRI contrast agent dose of 0.1 – 0.3 mmol kg−1 could be more severe.
There are also significant concentrations of sodium and potassium ions present in vivo,
however, in light of the small binding constant found for Ca2+ (Table 4) and given that the
binding constants of Na+ and K+ with the free ligand were so much weaker than that of
Ca2+, the formation of GdL·M complexes with these ions were not studied by potentiometry.
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The effect of metal ions on relaxivity and the origins of the pH response
To assess whether Ca2+ or other endogenous metal ions might have an effect on the relaxivity
of Gd1, the pH relaxivity profile was recorded in solutions that simulate the levels of these
ions in vivo (135 mM NaCl, 5 mM KCl and 2.5 mM CaCl2). The relaxivity profile measured
in the presence of these ions was similar to that obtained in the absence of these cations (Figure
3). The primary difference between the two profiles is a small shift in the relaxivity maxima
from pH 6.3 to pH 6.0 in the presence of endogenous metal ions. This is presumably the result
of a small reduction in the protonation constants of Gd1 resulting from the presence of the
metal ions (compare the first protonation constants of Gd1 (7.20, Table 3) versus Gd1•Ca2+
(6.94, Table 4)). The concomitant shift in the relaxivity maxima and change in phosphonate
group protonation constants indicates that the phosphonate groups are indeed responsible for
the pH sensitive relaxivity of this complex. Thus, although it may be important to account for
the effect of endogenous metal ions when using Gd1 to determine pH, the presence of these
metal ions does not diminish the utility of Gd1 as a pH sensor in vivo.
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The involvement of the phosphonate pendant arms in defining the relaxivity of Gd1 is further
supported by the potentiometric data. From the protonation constants reported in the previous
section, it is possible to generate a speciation diagram of the different protonation states of
Gd1. When this speciation diagram is plotted on the same axis as the pH dependent relaxivity
profile of Gd1, the significance of protonation of the phosphonate groups becomes immediately
apparent (Figure 5). The relaxivity maximum at pH 6.3 is exactly coincidental with the
maximum concentration of the diprotonated complex, GdLH23−, suggesting that it is this
species that has the maximal effect on the measured relaxivity. A multiple regression fitting
of these data to Eqn. 1 was performed to estimate the relaxivity of each protonated species and
thus the contribution of each species to the observed relaxivity. For this analysis, it was assumed
that the fully deprotonated species, GdL, the only species present above pH 9.5, represents the
outer sphere contribution to the relaxivity at each pH value. With this assumption, r1is could
be simplified to Eqn. 2. Statistically significant (α = 0.05) relaxivity values for each species
were found with a regression coefficient (<r1os>2) of 0.96 (Table 5). The significance of
protonation state of the phosphonates to the relaxivity of each species is immediately apparent.
The highest relaxivities are observed for those species that contain a mixture of mono and

Inorg Chem. Author manuscript; available in PMC 2008 September 12.

Kálmán et al.

Page 7

unprotonated phosphonates, and the highest relaxivity is observed when these are balanced,
i.e. for GdLH23−.

NIH-PA Author Manuscript

(1)

(2)

NIH-PA Author Manuscript

To investigate this further, variable temperature relaxivity (20 MHz) measurements of Gd1
were carried out at pH 6.2 (near the relaxivity peak at 25 °C) and at pH 8.3 (near the relaxivity
minimum at 25 °C). These data are shown in Figure 6, along with previously published data
for Gd2.41 There are three contributors to relaxivity: the contribution from an exchangeable
inner-sphere water (r1is), the contribution from long lived (ps – ns) waters/protons in the second
sphere (r1ss), and outer-sphere relaxation determined by the distance of closest approach and
the water diffusion rate (r1os). Outer- and second-sphere relaxivity will always increase
inversely with temperature; the correlation times for these processes are so short that the fast
exchange condition is always met. For gadolinium complexes of the size of Gd1, the T1 of the
coordinated water protons (T1M) is on the order of 1 – 10 µs. Lanthanide complexes of DOTAtetraamide complexes have very slow inner-sphere water exchange rates with water residency
times on the order of microseconds.12, 20, 41 The relaxivity of the GdDOTA-tetraamide
complexes can therefore span the slow to intermediate to fast exchange regime over the liquid
water temperature range. The result is that relaxivity first increases with temperature (slow
exchange, τM > T1M) and then decreases (fast exchange, T1M > τM).
Qualitatively the data in Figure 6 are quite revealing. The sample at pH 8.3 has high relaxivity
at low temperature that decreases as temperature is increased until about 310 K when the
relaxivity starts to increase. This is consistent with relaxivity dominated by outer-and secondsphere mechanisms at low temperatures, but with little contribution from the slow exchanging
inner-sphere water protons. As temperature increases, these inner-sphere protons exchange
more rapidly and contribute significantly to relaxivity. Going higher in temperature, one would
expect relaxivity to peak and then decline as the inner-sphere exchangeable protons move out
of the slow exchange regime. This behaviour has been observed in other systems, notably
Gd2 (Figure 6). The temperature dependence of the sample at pH 6.2 is quite different in that
the relaxivity always decreases with temperature, although this decline is not mono-exponential
and there is a plateau of sorts between 300 – 320 K. One explanation for change in the
temperature profile is more rapid exchange of the inner-sphere water protons at pH 6.2, moving
the system out of slow exchange at a lower temperature. Another possibility is an increase in
the 2nd sphere relaxivity of the complex due to phosphonate protons with long residence
lifetimes at this lower pH.
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Comparing the relaxivity of Gd1 at low temperatures with that of Gd2 it is clear that a
significant 2nd-sphere effect contributes to the relaxivity of Gd1. A similar second sphere
contribution has been observed with other gadolinium-phosphonate complexes in which the
phosphonate groups is bound directly to gadolinium.42–44 This second-sphere effect
complicates any attempts to analyze the data in a quantitative sense and, given the complex
speciation of Gd1 in solution (Figure 5), an unambiguous analysis of the data is impossible.
Nevertheless, it was found to be instructive to model the temperature dependence of Gd1 to
two simple models, each looking at a mechanistic extreme. In both models, it was assumed
that only one species is present at each pH. Model I took the assumption that the outer- and
second-sphere contributions to relaxivity at a given temperature were the same regardless of
pH and that their sum (r1os + r1ss) followed an exponential dependence with temperature. It
was also assumed that the correlation time for inner-sphere relaxation is the same at both pH
values, i.e. that rotational diffusion and electronic relaxation do not change with pH, and that
this correlation time has an exponential dependence with temperature. Model I tests whether
Inorg Chem. Author manuscript; available in PMC 2008 September 12.
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the differences in r1 versus temperature for the two pH samples can be explained solely by a
change in the exchange rate of the inner-sphere protons. The best fit of Model I to the
experimental data obtained for Gd1 is shown in Figure 7a (model details and parameters can
be found in supporting information). Also shown are the contributions from second- and outersphere relaxivity and the inner-sphere contributions at both pH values. From Figure 7a is can
clearly be seen that this simple model explains the data well and supports the hypothesis that
relaxivity differences are a result of different inner-sphere proton exchange rates.
Model II takes the other extreme and assumes that the inner-sphere proton exchange rate is the
same at both pH values. In this model, it was assumed that the outer-sphere relaxivity of
Gd1 is the same at both pH values and is identical to that determined for Gd2. Model II considers
a separate second-sphere component to relaxivity that is different at the two pH values. Model
II tests whether the differences in r1 versus temperature for the Gd1 at two different pH values
can be explained solely by second-sphere effects. The best fit to the data using Model II is
shown in Figure 7b and clearly does not explain the data well. The only way to reproduce the
"bulge" in the pH 6.2 data and the high temperature increase in the pH 8.3 data is with different
inner-sphere proton exchange rates.
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Since it is certain that Gd1 does have a second-sphere contribution to relaxivity the reality of
the situation probably lies somewhere between these two models. However, it appears probable
that inner-sphere water proton exchange is significantly faster at pH 6.2 than at pH 8.3. The
rate of whole water exchange in Dy1 was found to be unaffected by changes in pH,13 thus it
must be the rate of prototropic exchange in Gd1 that is altered by pH. Presumably GdLH23−,
the predominant species in solution at pH 6.2, exhibits more rapid prototopic exchange of the
coordinated water protons with those of the bulk solvent than do the other protonated states of
the complex. The phosphonates in the GdLH23− species, two of which are completely
deprotonated and two of which are monoprotonated, must be responsible for this rapid
prototropic exchange. One can envision a situation in which the two deprotonated
phosphonates located trans to one another in the complex are close enough to the coordinated
water molecule to act as general bases for deprotonating the Gd3+-bound water molecule. The
mono-protonated phosphonates then act as acids, simultaneously contributing protons to the
coordinated water molecule as illustrated in Figure 8. The relaxed protons, once transferred
from the water molecule to the phosphonate groups, may then be exchanged with protons in
the bulk solvent resulting in transfer of the relaxation of the bulk solvent. In this scenario, the
presence of two base and two acid equivalents, in a trans orientation, would be expected to be
the most efficient configuration for promoting this proton exchange reaction. Thus, it is not
surprising that the complex GdLH23− exhibits the highest relaxivity of all protonation species.
The protonated forms, GdLH4− and GdLH32−, also exhibit high relaxivities because, while not
as well balanced in terms of acidic and basic phosphonates as in GdLH23−, they are still both
able to catalyze prototropic exchange through a mixture of acids and bases. Once the
phosphonates are unable to supply either acidic or basic groups, catalysis by prototropic
exchange ceases and relaxivity drops off to values similar to that observed for other DOTAtetraamide derivatives.

Conclusions
Gd1 changes relaxivity over a pH range that is near ideal for measuring pH in vivo.14–16 Care
must be taken when preparing samples of Gd1 because the ligand can form distinctly different
complexes with Gd3+, the complex formed being strongly influenced by the initial pH at which
the complexation reaction is run. The current study shows that the complexation reaction should
be run at a pH no lower than 9 to produce only the desired pH sensitive, Type II product needed
for imaging pH by MRI. A Type I complex formed under more acidic conditions has a higher
relaxivity at lower pH values than the Type II complex so even small amounts of this product
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can affect the calibration curve needed for quantifying tissue pH. Other adventitious metal ions
present in biological samples do bind with Gd1 to form GdL•M ternary complexes. Ca2+ offers
the greatest potential for interference because the relaxivity versus pH curve is altered
somewhat in the presence of this ion, although calibration curves run in the presence of Ca2+
should easily account for these differences. Potentiometric and relaxometric data for Gd1 at
different pH values show that it is the phosphonates of the pendant arms that gives the complex
its unique pH responsive behaviour. When the phosphonate groups of one complex are able to
act in concert as acids and bases, catalysis of prototropic exchange results leads to an enhanced
relaxivity over a pH range that is useful for biological pH imaging.

Experimental Section
General
1H NMR spectra were recorded on a JOEL Eclipse 270 spectrometer operating at 270.17 MHz,
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a Varian Mercury 300 spectrometer operating at 299.95 MHz and a Varian Inova 500
spectrometer operating at 499.95 MHz. 31P NMR spectra were recorded on a Varian Mercury
300 spectrometer operating at 121.47 MHz. Longitudinal relaxation times were measured using
the inversion recovery method on a MRS-6 NMR analyzer from the Institut “Jožef Stefan”,
Ljubljana, Slovenjia operating at 20 MHz. Relaxivity was determined by linear regression
analysis of relaxation rates of six solutions (0.5 – 10 mM). The pH of samples for relaxivity
measurements were adjusted by addition of either lithium hydroxide monohydrate or ptoluenesulfonic acid monohydrate in order to avoid dilution.
Synthesis
Diethyl phthalimidomethylphosphonate (3)17—Triethylphosphite (40.53 g, 243.9
mmol) and N-bromomethylphthalimide (48.8 g, 203.3 mmol) were heated, neat, to 90 °C for
3 hours. A distillation apparatus was then fitted and the reaction temperature increased to 105
°C until no more distillate was produced. The reaction was allowed to cool to room temperature
and the residue dissolved in diethyl ether (300 mL). Hexanes (600 mL) were added and the
resulting solution cooled to −20 C and the product allowed to crystallize. The crystals were
recovered by filtration and dried under vacuum to afford the title compound as a colourless
solid (59.7 g, 99 %).
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mp = 63.5–64 °C; 1H NMR (300 MHz, CDCl3) δ 7.84 (2H, dd, 3JH-H = 6 Hz, 4JH-H = 3 Hz,
Ar), 7.71 (2H, dd, 3JH-H = 6 Hz, 4JH-H = 3 Hz, Ar), 4.18 (4H, q, , 3JH-H = 7 Hz, CH2CH3),
4.07 (2H, d, , 2JH-P = 11 Hz, NCH2P), 1.30 (6H, t, 3JH-H = 7 Hz, CH2CH3); 13C NMR (300
MHz, CDCl3) δ 167.1 (C=O), 134.4 (Ar), 132.2 (Ar-CO), 123.7(Ar), 63.0 (d, 2JC–P = 6 Hz,
OCH2), 33.5 (d, 1JC–P = 157 Hz, NCH2P), 16.5 (d, 3JC–P = 6 Hz, OCH2CH3); νmax / cm−1
(ATR) 2984, 2930, 1774 (C=O), 1716 (C=O), 1467, 1401, 1381, 1306, 1243, 1050, 1018, 968,
899, 718; m/z (ESMS, ES+) 242 (100%, [(M-2Et)+3H]+), 270 (25%, [(M-Et)+2H]+), 298
(21%, [M+H]+), 320 (24%, [M+Na]+); Anal. Found C = 52.5 %, H = 5.8 %, N = 4.6 %,
C13H16NO5P·requires C = 52.5 % H = 5.4 % N = 4.7 %.
Diethyl aminomethylphosphonate (4)17, 18—Hydrazine (2.1 mL, 60 mmol) was added
to a solution of the phthalimide 3 (16.05 g, 50 mmol) in absolute ethanol (200 mL). The reaction
was stirred at room temperature overnight before being heated at reflux for 3 hours. The
reaction mixture was then cooled to room temperature and then placed in the refrigerator for
several hours. The precipitate that formed was collected by suction filtration and washed with
CH2Cl2. The solvents were then removed under reduced pressure and the residue purified by
column chromatography over silica gel eluting with MeOH:Et2O (1:2) to afford the title
compound as a colourless oil (6.11 g, 73%).
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Rf = 0.3 (1:2, MeOH:Et2O, SiO2); 1H NMR (300 MHz, CD3CN) δ 4.01 (2H, q, 3JH-H = 7 Hz,
OCH2CH3), 3.98 (2H, q, 3JH-H = 7 Hz, OCH2CH3), 2.87 (2H, d, 2JH-P = 11 Hz, NCH2P), 2.28
(2H, s br, NH2), 1.21 (6H, t, 3JH-H = 7 Hz, CH2CH3); 13C NMR (300 MHz, CD3CN) δ 62.1
(d, 2JC-P = 7 Hz, OCH2), 37.2 (d, 1JC-P = 151 Hz, NCH2P), 16.2 (d, 3JC-P = 6 Hz,
OCH2CH3); νmax / cm−1 (ATR) 3383 (NH), 3297 (NH), 2980, 2930, 2907, 1662 (NH), 1392,
1228, 1163, 1050, 1021, 960; m/z (ESMS, ES+) 139 (100%, [(M-Et)+2H]+), 168 (66%, [M
+H]+)
Diethyl bromoacetamidomethylphosphonate (5)—The amine 4 (7.0 g, 42.0 mmol)
was added dropwise to a mixture of bromoacetyl bromide (3.7 mL, 42.0 mmol) and potassium
carbonate (7.0 g, 51.0 mmol) in benzene (50 mL), cooled to 0 °C in an ice bath, over 30 minutes.
The reaction was allowed to warm to room temperature and then stirred for 18 h. The reaction
mixture was filtered and the solvents removed under reduced pressure. The residue was purified
by column chromatography over silica gel eluting with 10% MeOH in Et2O. The title
compound was obtained as a colourless solid (9.6 g, 79 %).
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Rf = 0.5 (10% MeOH in Et2O , SiO2); mp = 85–86.5 °C; 1H NMR (270 MHz, CDCl3) δ 7.46
(1H, s br, NH), 4.13 (2H, q, 3JH-H = 7 Hz, OCH2CH3), 4.10 (2H, q, 3JH-H = 7 Hz,
OCH2CH3), 3.87 (2H, s, BrCH2CO), 3.70 (2H, dd, 3JH-H = 6 Hz, 2JH-P = 12 Hz, NCH2P), 1.31
(6H, t, 3JH-H = 7 Hz, CH2CH3); 13C NMR (270 MHz, CDCl3) δ 166.1 (d, 3JC-P = 6 Hz, C=O),
62.9 (d 2JC-P = 6 Hz, OCH2), 35.4 (d, 1JC-P = 157 Hz, NCH2P) 28.5 (BrCH2CO), 16.4
(d, 3JC-P = 6 Hz, OCH2CH3); νmax / cm−1 (ATR) 3254 (NH), 3058 (NH), 2983, 1669 (C=O),
1557, 1394, 1207, 1021, 979, 830; m/z (ESMS, ES-) 288 (100%, [M-H]−), the appropriate
isotope pattern was observed; Anal. Found C = 29.6 %, H = 5.5 %, N = 4.8 %,
C7H15BrNO4P·requires C = 29.2 % H = 5.3 % N = 4.9 %.
1,4,7,10-Tetraazacyclododecane-1,4,7,10- tetraacetamidomethylene-(diethyl)
phosphonate (6)—Cyclen (0.43 g, 2.5 mmol) was dissolved in acetonitrile (10 mL).
Potassium carbonate (1.5 g, 11.0 mmol) and the bromoacetamide 5 (2.88 g, 10.0 mmol) were
added and the reaction mixture stirred for 6 h at 60 °C. The reaction mixture was filtered and
the solvents removed under reduced pressure. The residue was taken up into chloroform and
heated under reflux for 30 minutes. A precipitate formed that was isolated by filtration. The
solids were dried under vacuum to afford the title compound as pale yellow solid (1.52 g, 61
%).
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mp = 150–150.5 °C; 1H NMR (270 MHz, CDCl3) δ 7.67 (4H, s br, CONH), 3.87 (8H,
q, 3JH-H = 7 Hz, OCH2CH3), 3.84 (8H, q, 3JH-H = 7 Hz, OCH2CH3), 3.46 (8H, dd, 3JH-H = 5
Hz, 2JH-P = 11 Hz, NCH2P), 2.92 (8H, s, NCH2CO), 2.49 (16H, s, ring CH2), 1.05 (24H,
t, 3JH-H = 7 Hz, CH2CH3); 13C NMR (270 MHz, CDCl3) δ 170.9 (C=O), 62.3 (OCH2), 58.9
(NCH2CO), 53.8 (ring CH2), 34.2 (d, 1JC-P = 157 Hz, NCH2P), 16.3 (OCH2CH3); 31P NMR
(300 MHz, D2O) δ 25.65; νmax / cm−1 (ATR) 3270 (NH), 2982, 2826, 1670 (C=O), 1540, 1226.
1050, 1023, 975; m/z (ESMS, ES+) 1002 (63%, [M+H]+), 1024 (100%, [M+Na]+); Anal.
Found C = 41.6 %, H = 7.1 %, N = 10.7 %, C36H76N8O16P4·0.5HBr requires C = 41.5 % H =
7.4 % N = 10.8 %.
1,4,7,10-Tetraazacyclododecane-1,4,7,10- tetraacetamidomethylene
phosphonic acid dihydrobromide (1)—The octaethyl ester 6 (0.8 g, 0.8 mmol) was
dissolved in a 30% solution of HBr in acetic acid (8 mL). The resulting solution was stirred at
RT for 18 h. The solvents were removed under reduced pressure and the residue taken up in
EtOH (5 mL) the solvents were again removed under reduced pressure. The solid residue was
then taken up into MeOH (5 mL) and the title compound precipitated by drop-wise addition
of Et2O. The resulting precipitate was isolated, dissolved in water and freeze dried to afford a
colourless solid (0.53 g, 86 %).
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mp = 247 °C, decomposes; 1H NMR (300 MHz, D2O) δ 3.67 (8H, s br, NCH2CO), 3.47 (8H,
d, 2JH-P = 12 Hz, NCH2P), 3.17 (16H, s br, ring CH2); 13C NMR (270 MHz, D2O) δ 170.7
(br, C=O), 55.0 (NCH2CO), 50.0 (br, ring CH2), 36.7 (d, 1JC-P = 150 Hz, NCH2P); νmax /
cm−1 (ATR) 3235 (NH), 3070 (NH), 2966, 2860, 1672 (C=O), 1556, 1555, 1392, 1300, 1186,
1151, 1083, 990, 918; m/z (ESMS, ESI+) 478 (100%, [Na8L+2H]2+); Anal. Found C = 23.1
%, H = 5.7 %, N = 10.8 % C20H44N8O16P4·2.2HBr·4.6H2O requires C = 23.2 %, H = 5.4 %,
N = 10.8 %
Potentiometric Titrations
Materials—Stock solutions of CaCl2, ZnCl2, CuCl2, and GdCl3 were prepared from
analytical-grade salts (Aldrich and Sigma, 99.9%), all other solutions were prepared from the
highest analytical grade materials commercially available, using HPLC grade water (Omni
Solv). The concentrations of the stock solutions were determined by complexometric titration
using a standardized Na2H2EDTA solution in the presence of calconcarboxylic acid (CaCl2),
eriochrome black-T (ZnCl2), murexide (CuCl2), and xylenol orange (LnCl3) as an indicator.
A stock solution of the ligand was prepared, and the ligand concentration was determined by
pH potentiometry on the basis of the titration curves obtained in the absence and presence of
excess CaCl2. Aliquots from the stock solution of 1 were diluted into 1.0 M solutions of
Me4NCl and KCl and the pH adjusted to ~1.7 with HCl. These solutions were titrated with
0.2173M Me4NOH (Me4NCl) or 0.1679M KOH (KCl) to a final pH of ~12.5.
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Measurements made using KCl for ionic strength—The potentiometric measurements
were carried out with an automatic titration system. The pH was measured in each titration
with a Ross semi-micro combination electrode (Orion) combined with a Thermo Orion
IonAnalyzer EA 940. The samples were titrated using a model 665 Metrohm Dosimat
autoburet. All potentiometric titrations were conducted under an argon atmosphere and the cell
was maintained at a constant 25 ± 0.1 °C by using a circulating water bath. The titrated solutions
(10 mL) were stirred. The electrode was calibrated by KH-phtalate (pH 4.005) and Natetraborate (pH 9.180) (Alfa Aesar). Titrations of each sample were performed over the pH
range 1.7–12.5, the concentrations of the 1 and the Gd1 were 0.002 M in the samples and 1 M
KCl was used to maintain the ionic strength. Hydrogen ion concentrations were calculated
from the measured pH values using the method proposed by Irving et. al.45 The value of
pKw used at I = 1.0 (KCl) was 13.81 which was determined experimentally under similar
conditions to that used for the titrations.
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Measurements made using Me4NCl for ionic strength were similar to that described
previously except that the titrations were performed with a Radiometer PHM93 pH-meter, an
ABU 80 autoburet, and Metrohm 6.0234.100 combined electrode and the volume of the titrated
solutions were 5 mL. The value of the pKw at I = 1.0 (Me4NCl) was determined experimentally
and found to be 14.06. Protonation constants were calculated from the potentiometric titrations
curves using the program PSEQUAD.46

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

The 1H NMR spectra of Yb1 complexes synthesized and recorded at a) pH 1, b) pH 9. The
spectra were recorded in D2O at 296K and 270 MHz (the peaks arising from HOD are labelled
with asterisks).
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Figure 2.

UV-visible absorption spectra of Ce1 (top) prepared at pH 1 (solid line) and pH 9 (dashed line).
The absorption bands are similar to those observed for the Type I (solid line) and Type II
(dashed line) complexes of CeDOTA (bottom).
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Figure 3.

The effect of solution pH on the relaxivity of Gd1 (open circles), recorded at 25 °C and 20
MHz ([Gd1] = 1.0 mM). The effect of solution pH on the relaxivity of Gd1 in the presence of
135 mM NaCl, 5 mM KCl and 2.5 mM CaCl2 ([Gd1] = 1 mM) is also shown (filled diamonds).
Profiles recorded at 15 °C and 35 °C are provided as supplementary material.
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Figure 4.

Nuclear magnetic relaxation dispersion (NMRD) profiles for Gd1 at 25°C and pH 5 (open
circles), pH 6 (open diamonds), pH 7 (closed diamonds) and pH 8.5 (closed circles). The pH
for these experiments was maintained by using HEPES buffers.
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Figure 5.

The longitudinal relaxivity pH profile of Gd1 (25 °C, 20 MHz) (red circles) laid-over the
speciation diagram of Gd1. The blue line is the overall relaxivity of the system calculated from
the relaxivity of each species (Table 5) as determined by the regression analysis.
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Figure 6.

The temperature dependence of the relaxivity of Gd1 at pH 6.2 (open diamonds) and pH 8.3
(closed diamonds). The temperature dependence of the relaxivity of Gd2 is shown for
comparison (open circles), the calculated relaxivity (solid line), the outer-sphere contribution
(dotted line) and the inner-sphere contribution (dashed line) are also shown.
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Figure 7.

Fitting the temperature dependence of the relaxivity of Gd1 at pH 6.2 (blue) and pH 8.3 (red)
to: a) a model that fixes the outer and second sphere contributions (dotted black line) and fits
the data to changes in the inner sphere relaxivity (dashed lines). The fits are shown as solid
lines. b) a model that assumes no change in inner-sphere relaxivity (dashed black line) and
accounts for difference in relaxivity through changes in the second sphere contribution (dotdash lines). The outer-sphere contribution (dotted black line) and fits (solid lines are also
shown.
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Figure 8.
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A schematic representation, viewed down the Gd-OH2 axis, of how the phosphonates in
GdLH23− transfer protons between the coordinated water molecule and the bulk solvent. The
relaxed protons of the coordinated water molecule (shown in red) are removed from the water
molecule by the deprotonated phosphonates which act as bases. They are then replaced by
unrelaxed protons from the bulk water (shown in blue) which are supplied by the
monoprotonated phosphonates which are acting as acids.
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Synthesis of 1. Reagents and conditions: i.) P(OEt)3 / Δ; ii.) N2H4 / EtOH; iii.) BrCH2COBr /
K2CO3 / benzene; iv.) cyclen / K2CO3 / MeCN / 60°C; v.) 30% HBr / AcOH / RT.
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Table 1

The protonation constants of ligand 1 as determined by potentiometric titration at 25°C in either 1.0 M Me4NCl or
KCl. The correlation coefficients of these determinations are examined in the Supplementary Information (S4).
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log K1H
log K2H
log K3H
log K4H
log K5H
log K6H
log K7H
log K8H

1.0 M Me4NCl

1.0 M KCl

9.97 ± 0.03
7.84 ± 0.05
7.44 ± 0.04
7.01 ± 0.04
6.50 ± 0.04
5.91 ± 0.03
2.46 ± 0.04
1.92 ± 0.03

8.78 ± 0.03
7.69 ± 0.03
7.21 ± 0.04
6.66 ± 0.04
6.17 ± 0.04
5.44 ± 0.04
2.17 ± 0.05
1.1 ± 0.1
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Table 2

The thermodynamic stability constants of complexes formed between ligand 1 and sodium, potassium and calcium at
25°C in 1.0 M Me4NCl.
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log KML
log KMLH
log KMLH2
log KMLH3
log KMLH4
log KM2L
log KM2LH

Na+

K+

Ca2+

3.72 ± 0.03
7.87 ± 0.06
7.77 ± 0.04
–
–
–
–

2.34 ± 0.09
8.86 ± 0.06
–
–
–
–
–

11.16 ± 0.07
8.00 ± 0.07
7.22 ± 0.07
6.70 ± 0.07
5.93 ± 0.04
2.76 ± 0.05
7.60 ± 0.07
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Table 3

The protonation constants of the Type II complex of Gd1, 25°C,1.0 M KCl. The correlation coefficients of these
determinations are examined in the Supplementary Information (S4).

NIH-PA Author Manuscript

pKa
log KGdLH1
log KGdLH2
log KGdLH3
log KGdLH4

7.20 ± 0.01
6.47 ± 0.01
6.03 ± 0.01
5.36 ± 0.01
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Table 4

Stability constants (log KGdLM) and protonation constants (log KGdMLH) for the ternary complexes of Gd1 (25°C, 1.0M
KCl).
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Equilibrium

M = Ca2+

M = Zn2+

M = Cu2+

log KGdLM
log KGdLMH

1.87 ± 0.04
6.94 ± 0.05

5.28 ± 0.05
6.98 ± 0.02

5.39 ± 0.04
6.18 ± 0.04
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Table 5

The calculated water relaxivities of each protonated Gd1 species (calculated from the data of Figure 5).
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Species

r1 / mM−1s−1

GdL5−
GdLH4−
GdLH23−
GdLH32−
GdLH4−

3.4
5.50 ± 0.11
5.57 ± 0.17
4.77 ± 0.18
4.42 ± 0.11
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